Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3389/fcvm.2021.695206 http://scihub22266oqcxt.onion/10.3389/fcvm.2021.695206 34222385!8248804!34222385     free     free     free       Front+Cardiovasc+Med 2021 ; 8 (?): 695206 Nephropedia Template TP {{tp|p=34222385|t=2021. COVID-19 and Cardiomyopathy: A Systematic Review |pdf=|usr=}}{{34222385}} gab.com Text COVID-19 and Cardiomyopathy: A Systematic Review JO: Front Cardiovasc Med http://www.kidney.de/pget.php?&tw=1&pmid=34222385 #FOAvip Background: Cardiomyopathies (CMPs) due to myocytes involvement are among the leading causes of sudden adolescent death and heart failure. During the COVID-19 pandemic, there are limited data available on cardiac complications in patients with COVID-19, leading to severe outcomes. Methods: We conducted a systematic search in Pubmed/Medline, Web of Science, and Embase databases up to August 2020, for all relevant studies about COVID-19 and CMPs. Results: A total of 29 articles with a total number of 1460 patients were included. Hypertension, diabetes, obesity, hyperlipidemia, and ischemic heart disease were the most reported comorbidities among patients with COVID-19 and cardiomyopathy. In the laboratory findings, 21.47% of patients had increased levels of troponin. Raised D-dimer levels were also reported in all of the patients. Echocardiographic results revealed mild, moderate, and severe Left Ventricular (LV) dysfunction present in 17.13, 11.87, and 10% of patients, respectively. Conclusions: Cardiac injury and CMPs were common conditions in patients with COVID-19. Therefore, it is suggested that cardiac damage be considered in managing patients with COVID-19. Twit Text FOAVip COVID-19 and Cardiomyopathy: A Systematic Review ????Front Cardiovasc Med http://www.kidney.de/pget.php?&tw=1&pmid=34222385 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34222385 #FOAvip English Wikipedia <ref>{{Cite pmid|34222385}}</ref> COVID-19 and Cardiomyopathy: A Systematic Review #MMPMID34222385 Omidi F; Hajikhani B; Kazemi SN; Tajbakhsh A; Riazi S; Mirsaeidi M; Ansari A; Ghanbari Boroujeni M; Khalili F; Hadadi S; Nasiri MJ Front Cardiovasc Med 2021[]; 8 (?): 695206 PMID34222385show ga Background: Cardiomyopathies (CMPs) due to myocytes involvement are among the leading causes of sudden adolescent death and heart failure. During the COVID-19 pandemic, there are limited data available on cardiac complications in patients with COVID-19, leading to severe outcomes. Methods: We conducted a systematic search in Pubmed/Medline, Web of Science, and Embase databases up to August 2020, for all relevant studies about COVID-19 and CMPs. Results: A total of 29 articles with a total number of 1460 patients were included. Hypertension, diabetes, obesity, hyperlipidemia, and ischemic heart disease were the most reported comorbidities among patients with COVID-19 and cardiomyopathy. In the laboratory findings, 21.47% of patients had increased levels of troponin. Raised D-dimer levels were also reported in all of the patients. Echocardiographic results revealed mild, moderate, and severe Left Ventricular (LV) dysfunction present in 17.13, 11.87, and 10% of patients, respectively. Conclusions: Cardiac injury and CMPs were common conditions in patients with COVID-19. Therefore, it is suggested that cardiac damage be considered in managing patients with COVID-19. ?COVID-19 and Cardiomyopathy: A Systematic Review (epmc).pdf DeepDyve Pubget Overpricing